참고문헌
- Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T and Dive C (2017) Progress and prospects of early detection in lung cancer. Open Biol 7, 170070 https://doi.org/10.1098/rsob.170070
- Kaufman J and Stinchcombe TE (2017) Treatment of KRAS-Mutant Non-Small Cell Lung Cancer: The End of the Beginning for Targeted Therapies. JAMA 317, 1835-1837 https://doi.org/10.1001/jama.2017.3436
- Matikas A, Mistriotis D, Georgoulias V and Kotsakis A (2017) Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity. Crit Rev Oncol Hematol 110, 1-12 https://doi.org/10.1016/j.critrevonc.2016.12.005
- Cox AD, Der CJ and Philips MR (2015) Targeting RAS membrane association: back to the future for anti-RAS drug discovery? Clin Cancer Res 21, 1819-1827 https://doi.org/10.1158/1078-0432.CCR-14-3214
- De Roock W, De Vriendt V, Normanno N, Ciardiello F and Tejpar S (2011) KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol 12, 594-603 https://doi.org/10.1016/S1470-2045(10)70209-6
- Petermann E, Orta ML, Issaeva N, Schultz N and Helleday T (2010) Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell 37, 492-502 https://doi.org/10.1016/j.molcel.2010.01.021
- Zafar F, Seidler SB, Kronenberg A, Schild D and Wiese C (2010) Homologous recombination contributes to the repair of DNA double-strand breaks induced by highenergy iron ions. Radiat Res 173, 27-39 https://doi.org/10.1667/RR1910.1
- Su F, Mukherjee S, Yang Y et al (2014) Nonenzymatic role for WRN in preserving nascent DNA strands after replication stress. Cell Rep 9, 1387-1401 https://doi.org/10.1016/j.celrep.2014.10.025
- Alshareeda AT, Negm OH, Aleskandarany MA et al (2016) Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein. Breast Cancer Res Treat 159, 41-53 https://doi.org/10.1007/s10549-016-3915-8
- Nagathihalli NS and Nagaraju G (2011) RAD51 as a potential biomarker and therapeutic target for pancreatic cancer. Biochim Biophys Acta 1816, 209-218
- Maacke H, Jost K, Opitz S et al (2000) DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene 19, 2791-2795 https://doi.org/10.1038/sj.onc.1203578
- Balbous A, Cortes U, Guilloteau K et al (2016) A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells. BMC Cancer 16, 604 https://doi.org/10.1186/s12885-016-2647-9
- Kalimutho M, Bain AL, Mukherjee B et al (2017) Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae. Mol Oncol 11, 470-490 https://doi.org/10.1002/1878-0261.12040
- Roman M, Baraibar I, Lopez I et al (2018) KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol Cancer 17, 33 https://doi.org/10.1186/s12943-018-0789-x
- Eder S, Arndt A, Lamkowski A et al (2017) Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K). Cancer Lett 385, 160-167 https://doi.org/10.1016/j.canlet.2016.10.027
- Eilers M and Eisenman RN (2008) Myc's broad reach. Genes Dev 22, 2755-2766 https://doi.org/10.1101/gad.1712408
- Ischenko I, Zhi J, Hayman MJ and Petrenko O (2017) KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents. Oncotarget 8, 17995-18009 https://doi.org/10.18632/oncotarget.14929
- Perera D and Venkitaraman AR (2016) Oncogenic KRAS triggers MAPK-dependent errors in mitosis and MYCdependent sensitivity to anti-mitotic agents. Sci Rep 6, 29741 https://doi.org/10.1038/srep29741
- Grabocka E, Commisso C and Bar-Sagi D (2015) Molecular pathways: targeting the dependence of mutant RAS cancers on the DNA damage response. Clin Cancer Res 21, 1243-1247 https://doi.org/10.1158/1078-0432.CCR-14-0650
- Dietlein F, Kalb B, Jokic M et al (2015) A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. Cell 162, 146-159 https://doi.org/10.1016/j.cell.2015.05.053
- Zhao L, Pu X, Ye Y, Lu C, Chang JY and Wu X (2016) Association between genetic variants in DNA doublestrand break repair pathways and risk of radiation therapy-induced pneumonitis and esophagitis in nonsmall cell lung cancer. Cancers (Basel) 8, E23 https://doi.org/10.3390/cancers8020023
- Scarbrough PM, Weber RP, Iversen ES et al (2016) A cross-cancer genetic association analysis of the DNA repair and DNA damage signaling pathways for lung, ovary, prostate, breast, and colorectal cancer. Cancer Epidemiol Biomarkers Prev 25, 193-200 https://doi.org/10.1158/1055-9965.EPI-15-0649
- Rothschild SI, Gautschi O, Lara PN Jr, Mack PC and Gandara DR (2011) Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer. Curr Opin Oncol 23, 150-157 https://doi.org/10.1097/CCO.0b013e328341ee38
- O'Grady S, Finn SP, Cuffe S, Richard DJ, O'Byrne KJ and Barr MP (2014) The role of DNA repair pathways in cisplatin resistant lung cancer. Cancer Treat Rev 40, 1161-1170 https://doi.org/10.1016/j.ctrv.2014.10.003
- Chen P, Li J, Chen YC et al (2016) The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells. Cell Oncol (Dordr) 39, 511-522 https://doi.org/10.1007/s13402-016-0291-7
- Soucek L, Whitfield JR, Sodir NM et al (2013) Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev 27, 504-513 https://doi.org/10.1101/gad.205542.112
- Luoto KR, Meng AX, Wasylishen AR et al (2010) Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair. Cancer Res 70, 8748-8759 https://doi.org/10.1158/0008-5472.CAN-10-0944
- Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45, W98-W102 https://doi.org/10.1093/nar/gkx247